Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
Loading ARNA News...
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.32% | 73.35 | 0.9% | $628.11m | |
| CELG | Celgene Corporation | -0.08% | 131.26 | 1.1% | $437.57m | |
| AMGN | Amgen Inc. | 0.79% | 171.39 | 1.1% | $428.25m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.88% | 151.37 | 1.9% | $388.67m | |
| BIIB | Biogen Inc. | 2.14% | 294.08 | 1.2% | $369.29m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.85% | 468.54 | 2.7% | $323.23m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.99% | 136.55 | 1.9% | $224.00m | |
| ILMN | Illumina, Inc. | 0.12% | 194.15 | 3.5% | $222.63m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.96% | 37.43 | 19.8% | $145.52m | |
| INCY | Incyte Corporation | -1.61% | 124.34 | 2.6% | $135.50m | |
| CLVS | Clovis Oncology, Inc. | -0.15% | 71.77 | 18.0% | $123.60m | |
| KITE | Kite Pharma, Inc. | 1.02% | 128.09 | 16.1% | $116.66m | |
| TSRO | TESARO, Inc. | -0.89% | 112.99 | 14.7% | $114.54m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.01% | 83.07 | 4.4% | $113.75m | |
| A | Agilent Technologies, Inc. | 4.67% | 62.15 | 1.5% | $112.87m |
Company Profile
Arena Pharmaceuticals, Inc. is a biopharmaceutical company engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers a range of drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.